Godoy-Guzman, CCGodoy-GuzmanCardenas-Sankan, GGCardenas-SankanOrihuela-Diaz, PPOrihuela-DiazDiaz-Saldivar, PPDiaz-SaldivarGuajardo-Correa, EmanuelEmanuelGuajardo-CorreaMena-Silva, DenisseDenisseMena-Silva2025-04-232025-04-23201910.1071/RD18114https://sic.vriic.usach.cl/entities/publication/eebb3c1d-d46a-4954-9f57-7389db419343The anti-implantation effects of high oestradiol (E2) concentrations could be mediated by E2 metabolites. Herein, we examined whether 2-methoxyoestradiol (2ME) impairs embryo implantation via its target protein F-spondin. Mice on Day 3 of pregnancy were treated with E2 concomitantly with the cathecol-O-methyl transferase inhibitor OR486 and the number of implanted embryos was recorded 5 days later. The effect of 2ME or 4-methoxyoestradiol (4ME) on embryo implantation was also investigated. Plasma and uterine levels of 2ME were measured 0.5, 1 or 3 h after E2 treatment while the mRNA for spondin 1 (Spon1) and F-spondin were determined in the uterus 3, 6, 12 or 24 h after 2ME treatment. Finally, the effect of a neutralising F-spondin antibody on the anti-implantation effect of 2ME was explored. OR486 blocked the anti-implantation effect of E2; 2ME, but not 4ME, affected embryo implantation. The 2ME concentration was increased after 0.5 and 1 h in plasma and 3 h in uterine fluid following E2 treatment. 2ME increased levels of Spon1 at 12 and 24 h although F-spondin was increased at 12 h. F-spondin antibody blocked the effect of 2ME on embryo implantation. We conclude that 2ME impairs mouse embryo implantation via activation of F-spondin in the uterus. © 2018 CSIRO.en-USblastocystcathechol- O -methyltransferasehyperoestrogenicoestradioloestrogen metobolitesuterine fluid.https://doi.org/10.1071/RD18114